Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.
about
Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease.Safinamide: an add-on treatment for managing Parkinson's disease.Safinamide in the management of patients with Parkinson's disease not stabilized on levodopa: a review of the current clinical evidence
P2860
Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.
@en
type
label
Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.
@en
prefLabel
Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.
@en
P2860
P1476
Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.
@en
P2093
Paul Foley
Thomas Müller
P2860
P2888
P304
P356
10.1007/S40262-016-0449-5
P577
2016-09-24T00:00:00Z
P6179
1035683029